Literature DB >> 8307143

Antibiotic susceptibility and phage typing of methicillin-resistant Staphylococcus aureus clinical isolates from blood cultures of 692 patients in 15 Israeli hospitals.

Z Samra1, R Gadba.   

Abstract

Six hundred ninety-two clinical isolates of Staphylococcus aureus were collected from blood cultures of 692 patients in 15 Israeli hospitals over a two year period. Antibiotic sensitivity was tested by the standard disk diffusion technique. Of these isolates, 41.6% were methicillin-resistant (MRSA). All 288 MRSA isolates were sensitive to vancomycin and pristinomycin; 98.6% were sensitive to fucidine; 97.9% to imipenem; 79% to rifampicin; 63.6% to amikacin; 54.5% to augmentin; 36.4% to clindamycin; 12.6% to ciprofloxacin; 11.9% to cotrimoxazole and ofloxacin; 10.5% to gentamicin; 9.8% to erythromycin; and 8.4% to norfloxacin. Phage typing was determined by using the international set of phages. All the isolates that were sensitive to Group I phages, and 91.8% of those sensitive to Group II phages, were sensitive to methicillin. Of the isolates that were sensitive to Group III phages, 79.2% were methicillin-resistant and 72.4% of the latter were sensitive to phages 75/85. Of the isolates that were sensitive to Group III and miscellaneous phages, 50.7% were methicillin-resistant and 71% of the latter were sensitive to phages 75/85 as well.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307143     DOI: 10.1007/BF00209536

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  10 in total

1.  Phage typing of staphylococci.

Authors:  J E Blair; R E Williams
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

Review 2.  Methicillin-resistant Staphylococcus aureus.

Authors:  W Brumfitt; J Hamilton-Miller
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

3.  Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

4.  Methicillin-resistant staphylococci.

Authors:  F H Kayser; T M Mak
Journal:  Am J Med Sci       Date:  1972-09       Impact factor: 2.378

5.  Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins.

Authors:  J F Acar; P Courvalin; Y A Chabbert
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia.

Authors:  O Jessen; K Rosendal; P Bülow; V Faber; K R Eriksen
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

Review 7.  Staphylococcus aureus. The persistent pathogen (first of two parts).

Authors:  J N Sheagren
Journal:  N Engl J Med       Date:  1984-05-24       Impact factor: 91.245

8.  Vancomycin therapy for methicillin-resistant Staphylococcus aureus.

Authors:  T C Sorrell; D R Packham; S Shanker; M Foldes; R Munro
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

9.  Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus.

Authors:  L D Sabath
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

10.  WILD-TYPE VARIANTS OF EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUS.

Authors:  M H RICHMOND
Journal:  Biochem J       Date:  1965-03       Impact factor: 3.857

  10 in total
  1 in total

1.  Clonal Diversity and Epidemiological Characteristics of ST239-MRSA Strains.

Authors:  Marwa I Abd El-Hamid; Alaa H Sewid; Mohamed Samir; Wael A H Hegazy; Mosa M Bahnass; Rasha A Mosbah; Doaa M Ghaith; Eman Khalifa; Hazem Ramadan; Walaa A Alshareef; Hanan M Alshareef; Mohammed M Ghoneim; Mohammad M Al-Sanea; Mahmoud M Bendary
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.